T2DM Flashcards

1
Q

What is T2DM?

A

A combination of insulin resistance and beta cell failure resulting in hyperglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which groups of people does T2DM have a high prevalence in?

A

Ethnic groups that are moving from a rural to an urban lifestyle (South and East Asia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the three measurements used for glucose levels in assessing T2DM?

A

Fasting Glucose, 2-Hour Oral Glucose Tolerance Test (OGTT), HbA1c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name the values/terms for fasting glucose at a normal, intermediate and T2DM stage

A

Fasting Glucose - <6.1 mmol/L /
Impaired Fasting Glycaemia / >7 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name the values/terms for OGTT at a normal, intermediate and T2DM stage

A

Normal <7.7mmol/L ,
Intermediate - Impaired glucose tolerance , >11mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name the values/terms for HbA1c at a normal, intermediate and T2DM stage

A

Normal - <42mmol/mol .
Intermediate - Pre-diabetes , >48mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the type of insulin deficiency in T2DM called?

A

Relative insulin deficiency - not enough insulin production to overcome resistance
however usually enough insulin to prevent formation of ketones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does T2DM cause its effects on glucose secretion & absorption?

A

Insulin resistance and beta cell dysfunction lead to proinflammatory visceral fat, leading to decreased glucose uptake by adipocytes & skeletal muscle and increased hepatic glucose production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Howcan T2DM eventually lead to DKA

A

Long term diabetes causing insulin production to become completely compromised - insulin dependent
glucose toxicity to the pancreas can cause acute illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a hyperglycaemic clamp?

A

A test of measuring insulin sensitivity and secretion by increasing glucose dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does T2DM affect the prandial peak of insulin release?

A

first phase insulin release is lost, very small peak

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What happens to hepatic glucose production in T2DM and why?

A

Reduction in insulin action and an increase in glucagon action - increases HGO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does T2DM lead to glucose toxicity

A

Glucose insufficiently removed due to low insulin levels
Formation of glucose via the action of glucagon on the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does the relationship between insulin secretion and insulin sensitivity present in a control?

A

If you have a higher sensitivity of insulin, you will not secrete much insulin. This is an exponential relationship (even at extremely high sensitivity you still need a basal insulin level similar to others)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does the relationship between insulin secretion and insulin sensitivity change in a person with T2DM?

A

Reduced insulin sensitivity, however insulin secretion is not at the high level it should be - described as ‘falling off the curve’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Consequences of insulin resistance

A

Glucagon increased -> HGO increase
insulin dependent muscle glucose uptake is depleted
Adipocytes prod more NEFA causing triglyceride levels to increase

17
Q

Monogenic diabetes

A

single gene mutation - MODY
born with it

18
Q

Polygenic diabetes

A

T1DM/T2DM
polymorphisms increase the risk of diabetes

19
Q

Associations with T2DM

A

Obesity - especially visceral fat
Intrauterine environment - being the offspring of a woman with gestational diabetes,
growth retardation, low body weight increases action of fat prod genes

20
Q

What are 7 presentations of T2DM?

A

Hyperglycaemia,
Overweight,
Dyslipidaemia,
Fewer osmotic symptoms,
Complications of T2DM,
Insulin Resistance,
Later Insulin Deficiency

21
Q

What are 6 risk factors of developing T2DM?

A

Age, BMI, Ethnicity, PCOS, Genetics, Inactivity

22
Q

What is the first line screening test for T2DM, how many readings do you need, and why is this chosen?

A

HbA1c, need two tests of HbA1c > 48 if asymptomatic,
one test if symptomatic
more convenient to take blood supply in clinic than to do a fasting glucose test

23
Q

What is the glycaemic state often correlated with renal failure?

A

Hyperosmolar Hyperglycaemic State

24
Q

Hyperosmolar Hyperglycaemic State

A

Insufficient insulin for prevention of hyperglycemia, but sufficient to prevent lipolysis and ketogenesis
osmotic diuresis causes serious dehydration
Can also be caused by MI, infection

25
Management of T1DM
Exogenous insulin self monitoring glucose education
26
Management of T2DM
diet oral meds education remission/reversal - drastic diet (800 calories daily) or gastric bypass surgery
27
What are the 5 parts of assessment in T2DM consultations?
Weight, BP, glucose, Cholesterol, Complications (feet, retina)
28
Drug to reduce HGO
metformin
29
Drug that improves insulin sensitivity
Metformin and pioglitazone
30
Drug that boosts insulin secretion
Sulphonylureas DPP-4 inhibitors GLP1 agonists
31
Drug that inhibits glucose reabsorption
SGLT-2 inhibitor
32
Metformin
First line if dietary/lifestyle changes haven't worked Reduces insulin resistance causing an increase in HGO GI side effects contraindicated in severe liver, cardiac, renal failure
33
Sulphonylureas
Boost insulin secreting capability of b cells bind to ATP sensitive K+ channel and close it
34
Pioglitazone
Insulin sensitizer causes peripheral weight gain side effects bladder cancer, heart failure
35
GLP-1
gut hormone stimulates insulin and suppresses glucagon increases satiety short half life due to degradation by DPP4
36
Incretin effect
Oral glucose causes greater insulin production than IV glucose
37
DPP-4 inhibitors dipeptidyl peptidase-4
increase half life of exogenous GLP1 decrease glucagon/glucose no effect on weight
38
SGLT inhibitors
Inhibits Na-GLu transporter -> more glycosuria weight loss, lower hba1c lowers mortality improves CKD